AAAAAA

   
Results: 1-3 |
Results: 3
Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection
Authors: Colonno, RJ Genovesi, EV Medina, I Lamb, L Durham, SK Huang, ML Corey, L Littlejohn, M Locarnini, S Tennant, BC Rose, B Clark, JM
Citation: Rj. Colonno et al., Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection, J INFEC DIS, 184(10), 2001, pp. 1236-1245
Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis withvery low dose hepatitis B immune globulin
Authors: McCaughan, GW Spencer, J Koorey, D Bowden, S Bartholomeusz, A Littlejohn, M Verran, D Chui, AKK Sheil, AGR Jones, RM Locarnini, SA Angus, PW
Citation: Gw. Mccaughan et al., Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis withvery low dose hepatitis B immune globulin, LIVER TR S, 5(6), 1999, pp. 512-519
Targets for inhibition of hepatitis C virus replication
Authors: Littlejohn, M Locarnini, S Bartholomeusz, A
Citation: M. Littlejohn et al., Targets for inhibition of hepatitis C virus replication, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 219-227
Risultati: 1-3 |